Terms: = Breast cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
151 results:
1. An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma.
Wang X; Ren T; Liao C; Xie Y; Cao J
BMC Genomics; 2024 Feb; 25(1):205. PubMed ID: 38395786
[TBL] [Abstract] [Full Text] [Related]
2. Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International breast cancer Study Group (IBCSG) Trial 22-00.
Rusakiewicz S; Tyekucheva S; Tissot-Renaud S; Chaba K; Imbimbo M; Benedetti F; Kammler R; Hornfeld J; Munzone E; Gianni L; Thurlimann B; Láng I; Pruneri G; Gray KP; Regan MR; Loi S; Colleoni M; Viale G; Kandalaft L; Coukos G; Curigliano G
Eur J Cancer; 2024 Mar; 200():113535. PubMed ID: 38309015
[TBL] [Abstract] [Full Text] [Related]
3. The relationship between high ratios of CD4/foxp3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study.
Tenggara JB; Rachman A; Prihartono J; Rachmadi L; Panigoro SS; Heriyanto DS; Sutandyo N; Nasution IR; Rahadiati FB; Steven R; Betsy R; Juanputra S; Sudoyo AW
BMC Res Notes; 2024 Feb; 17(1):44. PubMed ID: 38308298
[TBL] [Abstract] [Full Text] [Related]
4. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
6. Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancer.
Lin L; Li H; Wang X; Wang Z; Su G; Zhou J; Sun S; Ma X; Chen Y; You C; Gu Y
Cancer Med; 2023 Dec; 12(24):21639-21650. PubMed ID: 38059408
[TBL] [Abstract] [Full Text] [Related]
7. Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer.
Gaui MFD; Amendola LC; Quintella DC; Canedo N; Bonomo A
Rev Assoc Med Bras (1992); 2023; 69(9):e20230276. PubMed ID: 37729362
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
[TBL] [Abstract] [Full Text] [Related]
9. Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative breast cancer Patients.
Lejeune M; Reverté L; Gallardo N; Sauras E; Bosch R; Mata D; Roso A; Petit A; Peg V; Riu F; García-Fontgivell J; Relea F; Vieites B; de la Cruz-Merino L; Arenas M; Rodriguez V; Galera J; Korzynska A; Plancoulaine B; Álvaro T; López C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511057
[TBL] [Abstract] [Full Text] [Related]
10. Spatial Distribution and Densities of CD103+ and foxp3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in breast cancer.
Chan R; Aphivatanasiri C; Poon IK; Tsang JY; Ni Y; Lacambra M; Li J; Lee C; Tse GM
Oncologist; 2024 Mar; 29(3):e299-e308. PubMed ID: 37491001
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Significance Of foxp3+ Tumour-Infiltrating Tregs In Egyptian breast cancer Patients.
Abdelkader MM; Saied EM; ElShourbagy SH; El-Anwer NM
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S146-S150. PubMed ID: 37482848
[TBL] [Abstract] [Full Text] [Related]
12. Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.
Zhao M; Xing H; He J; Wang X; Liu Y
Pathol Res Pract; 2023 Aug; 248():154687. PubMed ID: 37478522
[TBL] [Abstract] [Full Text] [Related]
13. foxp3 regulatory T cells on prognosis of breast cancer.
Usman AN; Ahmad M; Sinrang AW; Natsir S; Takko AB; Ariyandy A; Ilhamuddin I; Eragradini AR; Hasan II; Hasyim S
Breast Dis; 2023; 42(1):213-218. PubMed ID: 37458005
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive breast Carcinoma of No Special Type.
Zhao Y; Huang T; Jin X; Gong XM; Lu YZ
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):354-362. PubMed ID: 37278279
[TBL] [Abstract] [Full Text] [Related]
15. IL-6 Levels Correlate with prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal cancer.
Yamamoto T; Tsunedomi R; Nakajima M; Suzuki N; Yoshida S; Tomochika S; Xu M; Nakagami Y; Matsui H; Tokumitsu Y; Shindo Y; Watanabe Y; Iida M; Takeda S; Hazama S; Tanabe T; Ioka T; Hoshii Y; Kiyota A; Takizawa H; Kawakami Y; Ueno T; Nagano H
Ann Surg Oncol; 2023 Aug; 30(8):5267-5277. PubMed ID: 37222942
[TBL] [Abstract] [Full Text] [Related]
16. An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers.
Fukui R; Watanabe T; Morimoto K; Fujimoto Y; Nagahashi M; Ishikawa E; Hirota S; Miyoshi Y
Breast Cancer; 2023 Sep; 30(5):703-713. PubMed ID: 37115435
[TBL] [Abstract] [Full Text] [Related]
17. Complexity and diversity of foxp3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer.
Malla R; Adem M; Chakraborty A
Int Immunopharmacol; 2023 May; 118():110015. PubMed ID: 36931171
[TBL] [Abstract] [Full Text] [Related]
18. Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.
Tomioka N; Hatanaka KC; Okuyama D; Watanabe KI; Yamamoto M; Maeda H; Tachikawa H; Kuwahara S; Shimizu A; Suzuki H; Hatanaka Y; Takahashi M
Breast Cancer; 2023 May; 30(3):497-505. PubMed ID: 36892732
[TBL] [Abstract] [Full Text] [Related]
19. The prognostic values of foxp3
Sun Y; Wang Y; Lu F; Zhao X; Nie Z; He B
Clin Transl Oncol; 2023 Jun; 25(6):1830-1843. PubMed ID: 36692642
[TBL] [Abstract] [Full Text] [Related]
20. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis.
Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
J Pathol Clin Res; 2023 May; 9(3):151-164. PubMed ID: 36598153
[TBL] [Abstract] [Full Text] [Related]
[Next]
